Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)

Clinical trial NCT00706342 · COMPLETED

Trial details

NCT number: NCT00706342
Sponsor: Rigel Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic, Idiopathic

Start date: 2007-01-01
Primary completion: 2010-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.